Knowledge


2026-01-20

What factors should be considered when selecting materials for medical plastic packaging?

The selection of materials for medical plastic packaging must revolve around four core dimensions: safety, protection, compatibility, and compliance. This selection should be made in comprehensive consideration of the characteristics of the medical product and its intended use scenarios, with the following specific factors to be taken into account: Biocompatibility The material must be non-toxic, non-sensitizing, and free from leachable harmful substances, and it must not undergo any chemical reactions with the drugs or devices contained within the package. It must pass biocompatibility tests such as ISO 10993 to prevent inflammation or allergic reactions upon contact with the human body. Barrier Properties Depending on the requirements of the contents, select materials with high barrier properties against oxygen, water vapor, microorganisms, ultraviolet light, and other factors. For example, lyophilized drug packaging requires materials with high moisture-barrier properties to prevent moisture absorption and subsequent loss of efficacy, while sterile device packaging requires antimicrobial materials to maintain a sterile environment. Sterilization Compatibility The material must be resistant to commonly used medical sterilization methods, such as ethylene oxide sterilization, gamma-ray irradiation, and steam sterilization. After sterilization, it must not deform or degrade, nor release toxic substances. For instance, polypropylene (PP) is compatible with steam sterilization, whereas polyester (PET) is suitable for irradiation sterilization. Mechanical Properties The material must possess sufficient tensile strength, tear resistance, and impact resistance to meet the demands of stacking and handling during transportation and storage, thereby preventing package damage that could lead to contamination of the contents. Process Compatibility The material should be easy to process and form (e.g., by blow molding or heat sealing), with heat-seal strength meeting the required standards to ensure a tight, leak-proof seal. At the same time, it should support printing, enabling clear labeling of product information, sterilization marks, expiration dates, and other traceability-related content. Compliance The material must comply with regulations issued by the National Medical Products Administration as well as international standards such as ISO 11607 “Packaging for terminally sterilized medical devices.” It must also have complete certification and full traceability. Cost and Environmental Considerations While meeting performance requirements, cost control should also be taken into account; in certain applications, recyclability or biodegradability should be considered to comply with medical waste disposal regulations.

2026-01-20

How to Ensure the Barrier Properties of Medical Plastic Packaging Materials

To ensure the barrier performance of medical plastic packaging materials, rigorous control is required at four core stages: material selection, structural design, production process management, and testing and verification. The specific measures are as follows: Precisely select base barrier materials Prioritize resin raw materials that inherently possess high barrier properties to match the protection requirements of the packaged contents. For example, when packaging oxygen- or moisture-sensitive pharmaceuticals or medical devices, polyvinylidene chloride (PVDC), ethylene-vinyl alcohol copolymer (EVOH), or polyamide (PA) can be chosen; for products that must withstand sterilization, radiation-resistant and high-temperature-resistant modified PET or PP materials are suitable. At the same time, it is essential to ensure raw material purity to prevent impurities from compromising the compactness of the barrier layer. Optimize multilayer composite structure design When the barrier performance of a single material is limited, employ multilayer co-extrusion or lamination processes to combine barrier layers with support layers and heat-seal layers, creating a functionally complementary structure. For instance, a “PP/EVOH/PP” composite film uses an EVOH layer in the middle to block oxygen and water vapor, while the outer PP layers provide mechanical strength and heat-sealing performance. Alternatively, coating technologies—such as aluminum or silicon dioxide deposition—can be used to form a dense barrier layer on the surface of plastic films, enhancing their resistance to gases and light. Strictly control production process parameters During manufacturing, precise control of parameters such as temperature, pressure, and speed is necessary to prevent defects in the barrier layer, including pinholes, bubbles, and uneven thickness. For example, during co-extrusion, the extrusion temperature must be carefully regulated to avoid resin degradation that could reduce barrier performance; in lamination processes, adhesive must be applied uniformly to prevent voids between laminated layers; and during heat sealing, the sealing temperature and pressure should be precisely controlled to ensure complete and reliable seals, thereby preventing external substances from entering through sealed areas. Implement full-process testing and verification Finished products must undergo standardized testing to verify barrier performance. Common test items include: Gas permeability testing: measuring the rate at which gases such as oxygen and carbon dioxide pass through the packaging material; Water vapor transmission rate testing: determining the amount of water vapor that passes through the material under specified temperature and humidity conditions; Seal integrity testing: using negative-pressure or positive-pressure methods to check the completeness of the package seal and identify potential defects such as pinholes or microcracks. In addition, post-sterilization sampling inspections must be conducted to confirm that the sterilization process does not compromise the material’s barrier structure.

2026-01-20

How to determine whether the material of medical plastic packaging meets chemical stability requirements?

To assess the chemical stability of medical plastic packaging materials, it is necessary to combine standard testing methods with validation in real-world application scenarios. The core objective is to confirm that, throughout the entire lifecycle—from sterilization and storage to use—the material does not degrade, release harmful substances, or react with the packaged medical products. The specific approaches are as follows: Conduct compliance testing in accordance with national and international standards. Relevant tests shall be carried out in compliance with standards such as ISO 10993 (Biological evaluation of medical devices) and GB/T 16886, including: Extractables/Leachables Testing: Simulate sterilization and storage conditions to determine the levels of small-molecule substances leaching from the material into a simulated medium (e.g., water, ethanol), ensuring that the concentrations of these leachables remain within safe limits to prevent contamination of the packaged drugs or devices. Chemical Compatibility Testing: Directly contact the packaging with the packaged product, store under specified temperature and humidity conditions until the shelf life expires, and observe whether any chemical reactions occur, such as discoloration, swelling, cracking of the material, or changes in the product’s composition. Validation of Stability Under Simulated Sterilization Processes Different sterilization methods can affect the chemical stability of the material; therefore, post-sterilization performance testing is required: Steam Sterilization at High Temperatures: Test whether the material exhibits oxidative degradation or a reduction in molecular weight after repeated sterilization at 121°C or 134°C. Ethylene Oxide Sterilization: Determine the residual ethylene oxide and its derivatives in the material after sterilization, ensuring that their concentrations comply with the nationally prescribed safety limits. Gamma-Ray Sterilization: Verify whether the material generates toxic degradation products or experiences embrittlement, discoloration, or other adverse effects following irradiation. Long-Term Accelerated Aging Tests Conduct accelerated aging tests—such as increasing temperature and humidity—to simulate the storage conditions of the packaging during its shelf life and evaluate the material’s long-term stability: Analyze changes in the material’s chemical structure after aging using instruments such as infrared spectroscopy (IR) and differential scanning calorimetry (DSC). Assess whether the barrier properties and mechanical strength of the aged packaging have deteriorated, to prevent loss of the sterile barrier due to material degradation. Verification of Suitability for Clinical Application Scenarios Adjust test conditions according to the usage environment of the packaged product; for example: For reagent packaging used in low-temperature storage, test whether the material becomes brittle or releases substances under cold conditions. For packaging of implantable devices, conduct additional long-term in vivo simulation tests to confirm that any leachables from the material pose no risk of sensitization or mutagenicity.

2026-01-20

Why are medical plastic packaging regulations so stringent?

The stringent requirements for medical plastic packaging are centered on ensuring the safety and efficacy of medical products and protecting patient health, while also complying with industry regulatory standards. There are three key reasons for this: First, the need for a sterile barrier. Many medical devices and pharmaceuticals are supplied in a sterile condition, necessitating packaging with high barrier properties to prevent the ingress of moisture, oxygen, microorganisms, and other external contaminants, thereby safeguarding product integrity. For example, packaging for syringes and surgical blades must be completely sealed and puncture-resistant to avoid damage or microbial contamination during transportation and storage. Second, compatibility with sterilization processes. Most medical products undergo sterilization using methods such as steam at elevated temperatures or ethylene oxide; therefore, the packaging materials must withstand these conditions without releasing harmful substances and must maintain structural integrity. If the packaging fails to meet thermal resistance and chemical stability requirements, sterilization may be compromised, leading to product contamination. Third, compliance and traceability requirements. The medical industry is subject to rigorous oversight by regulatory authorities worldwide, and packaging must comply with standards such as ISO 11607, clearly labeling product information, sterilization date, expiration date, and other critical details to enable end-to-end traceability. In addition, packaging must exhibit robust mechanical strength to withstand stacking and handling during warehousing and logistics, thereby minimizing the risk of damage. In summary, the stringent standards governing medical plastic packaging serve as a critical link across the entire value chain—from manufacturing and sterilization to distribution and clinical use—and directly impact the safety of patient care.

2026-01-20

Does the choice of material for medical plastic packaging affect the product’s shelf life?

The selection of materials for medical plastic packaging directly affects the product’s shelf life, with the key determinants being the material’s sterile barrier performance and chemical stability. These two properties dictate whether a medical product can maintain a sterile and stable condition throughout its specified shelf life. Barrier Performance Determines Sterile Shelf Life The primary prerequisite for the shelf life of medical products is that the packaging continuously prevents the ingress of external microorganisms, moisture, and oxygen. Significant differences exist in the barrier properties among various materials: Polyamide (PA) and polyester (PET) exhibit excellent barrier properties, effectively blocking gases and moisture over long periods; when combined with polyethylene (PE) to form composite films, they can substantially extend the shelf life of implantable devices and high-end pharmaceuticals. Low-density polyethylene (LDPE), by contrast, has relatively poor barrier properties and is suitable only for packaging ordinary consumables with shorter shelf lives. If the material’s barrier performance is inadequate, external contaminants will gradually penetrate, leading to premature deactivation or contamination of the product and necessitating a reduction in its shelf life. Chemical Stability Prevents Product Deterioration If the material degrades during sterilization or storage, or if it releases small-molecule substances, these may react with the packaged product, accelerating its deterioration. Polypropylene (PP) boasts strong chemical stability, withstands high-temperature steam sterilization, and is unlikely to leach harmful substances, thereby ensuring the long-term stability of products such as infusion sets and syringes. In contrast, certain low-quality plastic materials may contaminate drugs or medical devices through additive migration, directly shortening the product’s shelf life and even posing safety risks. Age Resistance Meets Long-Term Storage Requirements The material’s resistance to aging and to fluctuations in temperature and humidity also impacts shelf life. For example, polycarbonate (PC) exhibits excellent weather resistance and is well suited for packaging reusable, sterilizable devices that require long-term storage; by contrast, conventional polyethylene (PE) tends to age and become brittle under intense light and high temperatures, making it unsuitable for meeting the demands of long-shelf-life storage.

< 1234 >